tert‐butyl N‐{[(8‐aminooctyl)amino]({[(tert‐butoxy)carbonyl]amino})methylidene}carbamate | 160677-42-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert‐butyl N‐{[(8‐aminooctyl)amino]({[(tert‐butoxy)carbonyl]amino})methylidene}carbamate
• 英文别名: Bis(1,1-dimethylethyl) [[(8-aminooctyl)imino]methylene]biscarbamate；tert-butyl N-[N'-(8-aminooctyl)-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamimidoyl]carbamate
• CAS: 160677-42-9
• 化学式: C₁₉H₃₈N₄O₄
• 分子量: 386.535
• InChiKey: FQPCRESDVNTGEN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  27
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.84
• 拓扑面积：
  115
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  tert‐butyl N‐{[(8‐aminooctyl)amino]({[(tert‐butoxy)carbonyl]amino})methylidene}carbamate 在 palladium 10% on activated carbon 、 氢气 、 二异丁基氢化铝 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 18.5h， 生成 tert-butyl N-(cyclopropylmethyl)-N-[N-[(2-methylpropan-2-yl)oxycarbonyl]-N'-[8-[4-[(2-methylpropan-2-yl)oxycarbonylamino]-2-oxo-1,3,5-triazacyclotridec-4-en-1-yl]octyl]carbamimidoyl]carbamate
  参考文献：
  名称：

  Novel Macrocyclic Amidinoureas: Potent Non-Azole Antifungals Active against Wild-Type and Resistant Candida Species

  摘要：

  Novel macrocyclic amidinourea derivatives 11, 18, and 25 were synthesized and evaluated as antifungal agents against wild-type and fluconazole resistant Candida species. Macrocyclic compounds 11 and 18 were synthesized through a convergent approach using as a key step a ring-closing metathesis macrocyclization reaction, whereas compounds 25 were obtained by our previously reported synthetic pathway. All the macrocyclic amidinoureas showed antifungal activity toward different Candida species higher or comparable to fluconazole and resulted highly active against fluconazole resistant Candida strains showing in many cases minimum inhibitory concentration values lower than voriconazole.

  DOI：

  10.1021/ml400187w
• 作为产物：
  描述：

  1,3-二(叔丁氧基羰基)胍 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 生成 tert‐butyl N‐{[(8‐aminooctyl)amino]({[(tert‐butoxy)carbonyl]amino})methylidene}carbamate
  参考文献：
  名称：

  Novel Macrocyclic Amidinoureas: Potent Non-Azole Antifungals Active against Wild-Type and Resistant Candida Species

  摘要：

  Novel macrocyclic amidinourea derivatives 11, 18, and 25 were synthesized and evaluated as antifungal agents against wild-type and fluconazole resistant Candida species. Macrocyclic compounds 11 and 18 were synthesized through a convergent approach using as a key step a ring-closing metathesis macrocyclization reaction, whereas compounds 25 were obtained by our previously reported synthetic pathway. All the macrocyclic amidinoureas showed antifungal activity toward different Candida species higher or comparable to fluconazole and resulted highly active against fluconazole resistant Candida strains showing in many cases minimum inhibitory concentration values lower than voriconazole.

  DOI：

  10.1021/ml400187w

文献信息

• Macrocyclization of Di-Boc-guanidino-alkylamines Related to Guazatine Components: Discovery and Synthesis of Innovative Macrocyclic Amidinoureas
  作者：Daniele Castagnolo、Francesco Raffi、Gianluca Giorgi、Maurizio Botta

  DOI：10.1002/ejoc.200801109

  日期：2009.1

  The synthesis of new and innovative macrocyclic amidinoureas from linear di-Boc-guanidino-alkylamines related to guazatine was accomplished. The macrocyclization reaction proceeds under mild conditions affording 11- to 16-membered rings with a new and previously undescribed structure in good yields. Enantiomerically pure macrocyclic amidinoureas were also synthesised. The strict correlation between

  完成了从与 guazatine 相关的线性二-Boc-胍基-烷基胺合成新的和创新的大环脒基脲。大环化反应在温和条件下进行，以良好的产率提供具有新的和以前未描述的结构的 11 至 16 元环。还合成了对映体纯的大环脒基脲。从生物学的角度来看，大环脒基脲和天然产物瓜扎汀之间的严格相关性也使它们非常具有活性。
• Design and synthesis of a novel inhibitor of T. Viride chitinase through an in silico target fishing protocol
  作者：Giorgio Maccari、Davide Deodato、Diego Fiorucci、Francesco Orofino、Giuseppina I. Truglio、Carolina Pasero、Riccardo Martini、Filomena De Luca、Jean-Denis Docquier、Maurizio Botta

  DOI：10.1016/j.bmcl.2017.06.016

  日期：2017.8

  unknown. In this work, we developed an in-silico target fishing procedure to identify a possible target for this class of compounds based on shape similarity, inverse docking procedure and consensus score rank-by-rank. Chitinase enzyme emerged as possible target. To confirm this hypothesis a novel macrocyclic derivative has been produced, specifically designed to increase the inhibition of the chitinase

  在过去的十年中，我们确定并开发了一种新型的抗真菌药物，即大环酰胺尿素。这些化合物对几种念珠菌有活性种类，包括对目前可用的抗真菌药物具有耐药性的临床分离株。这些分子的作用方式仍是未知的。在这项工作中，我们开发了一种计算机内目标捕捞程序，可以根据形状相似性，反向对接程序和共识分数逐级确定此类化合物的可能目标。几丁质酶成为可能的靶标。为了证实该假设，已经生产了新的大环衍生物，其被专门设计用于增加对几丁质酶的抑制。生物学评估强调了对新衍生物的更强的酶抑制作用，而其抗真菌活性可能由于药代动力学问题而下降。总的来说，我们的数据表明几丁质酶代表大环a脲的至少一个主要靶标。
• Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies
  作者：Domiziana Masci、Charlotte Hind、Mohammad K. Islam、Anita Toscani、Melanie Clifford、Antonio Coluccia、Irene Conforti、Meir Touitou、Siham Memdouh、Xumin Wei、Giuseppe La Regina、Romano Silvestri、J. Mark Sutton、Daniele Castagnolo

  DOI：10.1016/j.ejmech.2019.05.087

  日期：2019.9

  drug-resistant Gram + ve and Gram-ve pathogens at concentrations similar or lower than levofloxacin. Microbiology studies revealed that the plausible target of the pyrrole derivatives is the bacterial DNA gyrase, with the pyrrole derivatives displaying similar inhibitory activity to levofloxacin against the wild type enzyme and retaining activity against the fluoroquinolone-resistant enzyme.

  抗生素耐药性是全球范围内的主要威胁。革兰氏阳性和革兰氏阴性机会病原体对所有已知药物均产生耐药性，这主要是由于这些药物的过度使用和滥用以及制药行业缺乏新的抗生素开发。迫切需要发现在结构上没有创新性的抗菌剂。这项工作描述了对一系列ESKAPE细菌具有活性的新型1,5-二苯基吡咯化合物的鉴定，合成和生物学评估。新化合物在与左氧氟沙星相似或低于左氧氟沙星的浓度下，对野生型和抗药性革兰氏阳性和革兰氏阴性病原体均显示出高活性。
• 15-deoxyspergualin analogs, their method of preparation and their use in
  申请人：Fournier Industrie et Sante

  公开号：US05637613A1

  公开（公告）日：1997-06-10

  The present invention relates, by way of novel industrial products, to compounds which are structurally related to 15-deoxyspergualin and which have the formula ##STR1## in which: A is a single bond, a group --CH.sub.2 --, a group --CH.sub.2 O--, a group --CH.sub.2 NH--, a group --CH(OH)--, a group --CHF-- or a group --CH(OCH.sub.3)--, and n is equal to 6 or 8, and their addition salts. These novel compounds are useful especially as immunosuppressants. The invention further relates to the method of preparing said compounds.

  本发明涉及一种与15-去氧斯佩尔瓜林结构相关的化合物，其具有以下式的结构：A为单键、基团--CH₂--、基团--CH₂O--、基团--CH₂NH--、基团--CH(OH)--、基团--CHF--或基团--CH(OCH₃)--，n等于6或8，以及它们的加合盐。这些新型化合物特别适用于免疫抑制剂。该发明还涉及制备上述化合物的方法。
• Structure‐Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands ^†
  作者：Steffen Pockes、David Wifling、Armin Buschauer、Sigurd Elz

  DOI：10.1002/open.201900011

  日期：2019.3

  at the four histamine receptor (H1R, H2R, H3R, H4R) subtypes. Alkylated guanidines with different terminal functional groups and varied basicity, like amine, guanidine and urea were developed, based on the lead structure SK&F 91486 (2). Furthermore, heteroatomic exchange at the guanidine structure of 2 led to simple analogues of the lead compound. Radioassays at all histamine receptor subtypes were

  合成了具有不同功能和间隔基长度变化的新型烷基化杂芳基丙基胍，以确定它们在四种组胺受体（H 1 R、H 2 R、H 3 R、H 4 R）亚型中的行为。基于先导结构 SK&F 91486 ( 2 )，开发了具有不同末端官能团和不同碱度的烷基化胍，如胺、胍和脲。此外， 2的胍结构上的杂原子交换产生了先导化合物的简单类似物。完成了所有组胺受体亚型的放射测定，以及豚鼠 ( gp ) 回肠 ( gp H 1 R) 和右心房 ( gp H 2 R) 的器官浴研究。具有末端功能化的配体部分地导致高度亲和和有效的结构（两位数纳摩尔），这在组胺受体家族中表现出较差的选择性。虽然苯甲酰脲衍生物144显示出对人 ( h ) H 3 R 的偏好，但 S-甲基异硫脲类似物143在h H 4 R (pK i = 8.14) 上获得了高亲和力并具有中等选择性。后一个发现的分子基础得到了计算研究的支持。